gamma-aminobutyric acid has been researched along with Skin Diseases in 4 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gabapentin is a very promising medication in the treatment of post-herpetic neuralgia and pain." | 8.82 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Gabapentin is a very promising medication in the treatment of post-herpetic neuralgia and pain." | 6.42 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Gabapentin was first approved by the FDA in 1993 as an add-on treatment for partial epileptic seizures." | 6.42 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Over 150 articles reviewed its use for neuropathic pain, neuritis or neuralgia of various sorts." | 6.42 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Gabapentin is a very promising medication in the treatment of post-herpetic neuralgia and pain." | 4.82 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Gabapentin is a very promising medication in the treatment of post-herpetic neuralgia and pain." | 2.42 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Gabapentin was first approved by the FDA in 1993 as an add-on treatment for partial epileptic seizures." | 2.42 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| "Over 150 articles reviewed its use for neuropathic pain, neuritis or neuralgia of various sorts." | 2.42 | The role of gabapentin in treating diseases with cutaneous manifestations and pain. ( Scheinfeld, N, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wei-Chong, C | 1 |
| Yam, A | 1 |
| Ishida, H | 1 |
| Mitsui, K | 1 |
| Nukaya, H | 1 |
| Matsumoto, K | 1 |
| Tsuji, K | 1 |
| Scheinfeld, N | 1 |
| DeToledo, JC | 1 |
| Minagar, A | 1 |
| Lowe, MR | 1 |
| Ramsay, RE | 1 |
1 review available for gamma-aminobutyric acid and Skin Diseases
| Article | Year |
|---|---|
The role of gabapentin in treating diseases with cutaneous manifestations and pain.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Herp | 2003 |
3 other studies available for gamma-aminobutyric acid and Skin Diseases
| Article | Year |
|---|---|
Compression of the superficial branch of the radial nerve by calcinosis cutis causing neuropathic pain.
Topics: Analgesics; Calcinosis; Cyclooxygenase 2 Inhibitors; Etoricoxib; gamma-Aminobutyric Acid; Humans; Ma | 2010 |
Study of active substances involved in skin dysfunction induced by crowding stress. I. Effect of crowding and isolation on some physiological variables, skin function and skin blood perfusion in hairless mice.
Topics: Animals; Crowding; Female; gamma-Aminobutyric Acid; Mice; Mice, Hairless; Skin; Skin Diseases; Socia | 2003 |
Skin eruption with gabapentin in a patient with repeated AED-induced Stevens-Johnson's syndrome.
Topics: Acetates; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Hypersensitivity; Female | 1999 |